JP2018508523A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018508523A5 JP2018508523A5 JP2017546149A JP2017546149A JP2018508523A5 JP 2018508523 A5 JP2018508523 A5 JP 2018508523A5 JP 2017546149 A JP2017546149 A JP 2017546149A JP 2017546149 A JP2017546149 A JP 2017546149A JP 2018508523 A5 JP2018508523 A5 JP 2018508523A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cochleates
- cocreatate
- tissue
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562127799P | 2015-03-03 | 2015-03-03 | |
| US62/127,799 | 2015-03-03 | ||
| US201562162425P | 2015-05-15 | 2015-05-15 | |
| US62/162,425 | 2015-05-15 | ||
| US201562163212P | 2015-05-18 | 2015-05-18 | |
| US62/163,212 | 2015-05-18 | ||
| US201562239675P | 2015-10-09 | 2015-10-09 | |
| US62/239,675 | 2015-10-09 | ||
| US201562247641P | 2015-10-28 | 2015-10-28 | |
| US62/247,641 | 2015-10-28 | ||
| US201562264164P | 2015-12-07 | 2015-12-07 | |
| US62/264,164 | 2015-12-07 | ||
| PCT/US2016/020722 WO2016141203A1 (en) | 2015-03-03 | 2016-03-03 | Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018508523A JP2018508523A (ja) | 2018-03-29 |
| JP2018508523A5 true JP2018508523A5 (https=) | 2019-03-28 |
| JP6770524B2 JP6770524B2 (ja) | 2020-10-14 |
Family
ID=56848705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546149A Active JP6770524B2 (ja) | 2015-03-03 | 2016-03-03 | コクリエート、及び薬理活性物質の組織透過性を高めるためにそれを使用する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11389407B2 (https=) |
| EP (1) | EP3265060B1 (https=) |
| JP (1) | JP6770524B2 (https=) |
| KR (1) | KR20180004104A (https=) |
| CN (1) | CN107847443A (https=) |
| AU (1) | AU2016226151B2 (https=) |
| CA (1) | CA2978308C (https=) |
| WO (1) | WO2016141203A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3076336A1 (en) * | 2017-09-20 | 2019-03-28 | Atopic Medical, LLC | Compositions and methods for treating and ameliorating respiratory conditions and inflammation of mucosa |
| CN107621514B (zh) * | 2017-11-10 | 2020-09-29 | 成都美域高制药有限公司 | 高效液相色谱法测定磷酸特地唑胺对映异构体含量的方法 |
| KR101989789B1 (ko) * | 2017-11-30 | 2019-06-18 | (주) 에이치엔에이파마켐 | 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트 |
| WO2019199238A1 (en) * | 2018-04-09 | 2019-10-17 | Vet Products Research And Innovation Center Company Limited | Inorganic mineral entrapped in nanoparticle production method thereof |
| MX2022001871A (es) * | 2019-08-13 | 2022-03-11 | Matinas Biopharma Nanotechnologies Inc | Metodos de tratamiento de las infecciones por criptococo. |
| WO2024039733A1 (en) * | 2022-08-16 | 2024-02-22 | Matinas Biopharma Nanotechnologies, Inc. | Methods of controlling lipid nanocrystal particle size and lipid nanocrystals produced by such methods |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871488A (en) * | 1985-04-22 | 1989-10-03 | Albany Medical College Of Union University | Reconstituting viral glycoproteins into large phospholipid vesicles |
| US5643574A (en) * | 1993-10-04 | 1997-07-01 | Albany Medical College | Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| US5994318A (en) | 1993-10-04 | 1999-11-30 | Albany Medical College | Cochleate delivery vehicles |
| US6153217A (en) | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| US20030219473A1 (en) * | 2002-03-26 | 2003-11-27 | Leila Zarif | Cochleates made with purified soy phosphatidylserine |
| WO2004012709A1 (en) | 2002-08-06 | 2004-02-12 | Tuo Jin | Cochleates without metal cations as the bridging agents |
| US20050008686A1 (en) * | 2003-01-15 | 2005-01-13 | Mannino Raphael J. | Cochleate preparations of fragile nutrients |
| EP1624858B1 (en) | 2003-04-09 | 2018-06-06 | Rutgers, the State University of New Jersey | Novel encochleation methods |
| EP1631669A2 (en) | 2003-04-09 | 2006-03-08 | Biodelivery Sciences International, Inc. | Cochleate compositions directed against expression of proteins |
| ES2559828T3 (es) * | 2003-07-16 | 2016-02-16 | Protiva Biotherapeutics Inc. | ARN de interferencia encapsulado en lípidos |
| JP2007532573A (ja) * | 2004-04-09 | 2007-11-15 | バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド | ヌクレオチド−渦巻状組成物および使用の方法 |
| EP2704688B1 (en) | 2011-05-05 | 2019-07-10 | Matinas BioPharma Nanotechnologies, Inc. | Cochleate compositions and methods of making and using same |
| WO2013085152A1 (en) * | 2011-12-07 | 2013-06-13 | Union Korea Pharm Co., Ltd. | Combined antibiotics comprising cephalosporins and beta-lactamase inhibitors |
| KR102115718B1 (ko) * | 2012-07-30 | 2020-05-28 | 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 | 대두 포스파티딜세린으로 제조된 코클리에이트 |
| AU2016252885B2 (en) | 2015-04-22 | 2021-05-20 | Matinas Biopharma Nanotechnologies, Inc. | Compositions and methods for treating mycobacteria infections and lung disease |
| CA2987798A1 (en) | 2015-06-18 | 2016-12-22 | Matinas Biopharma Nanotechnologies, Inc. | Compositions and methods for treating inflammatory disease or conditions |
-
2016
- 2016-03-03 CA CA2978308A patent/CA2978308C/en active Active
- 2016-03-03 WO PCT/US2016/020722 patent/WO2016141203A1/en not_active Ceased
- 2016-03-03 KR KR1020177026735A patent/KR20180004104A/ko not_active Ceased
- 2016-03-03 CN CN201680026006.3A patent/CN107847443A/zh active Pending
- 2016-03-03 AU AU2016226151A patent/AU2016226151B2/en active Active
- 2016-03-03 US US15/554,921 patent/US11389407B2/en active Active
- 2016-03-03 JP JP2017546149A patent/JP6770524B2/ja active Active
- 2016-03-03 EP EP16759508.1A patent/EP3265060B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018508523A5 (https=) | ||
| US11518796B2 (en) | Engineered platelets for targeted delivery of a therapeutic agent | |
| Peng et al. | Local release of TGF‐β inhibitor modulates tumor‐associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy | |
| US20250195641A1 (en) | Immunotherapeutic constructs and methods of their use | |
| US10646460B2 (en) | Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compound | |
| AU2015254309A1 (en) | Muscle atrophy inhibitor containing quercetin glycoside | |
| JP2016515533A5 (https=) | ||
| CA3139714A1 (en) | Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor | |
| Li et al. | A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE−/− mice by reducing lesion necrosis and inflammation | |
| WO2021011496A1 (en) | Immunotherapeutic constructs and methods of their use | |
| US11110168B2 (en) | Nanoparticles, controlled-release dosage forms, and methods for delivering an immunotherapeutic agent | |
| Fang et al. | Atorvastatin suppresses Toll-like receptor 4 expression and NF-κB activation in rabbit atherosclerotic plaques. | |
| Chen et al. | Leukocyte–mimicking Pluronic–lipid nanovesicle hybrids inhibit the growth and metastasis of breast cancer | |
| US20190192555A1 (en) | Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy | |
| JP2018537514A5 (https=) | ||
| Yin et al. | An immune‐enhancing injectable hydrogel loaded with esketamine and DDP promotes painless immunochemotherapy to inhibit breast cancer growth | |
| SI3099307T1 (en) | Use of cladribine for the treatment of neuromyelitis of the visual nerve | |
| CN114040751A (zh) | 针对微卫星稳定型结直肠癌通过协同性免疫原性细胞死亡促进抗肿瘤响应的槲皮素和土木香内酯的纳米共递送 | |
| Fragassi | Rational development of intra-articular drug delivery systems for the treatment of osteoarthritis | |
| Ceccon | Ceritinib as a promising therapy for ALK related diseases | |
| EP4588511A3 (en) | Intestinal alkaline phosphatase-based treatments of metabolic disorders | |
| KR101577271B1 (ko) | 칼슘 이온 및 친수성 비스포스포네이트를 이용한 나노복합체의 제조방법 및 상기 나노복합체를 이용한 약물전달체 | |
| Niknafs et al. | An Approach to New Treatments for Osteoarthritis: Advancing Phenotype-Specific Treatments and the Promise of Nanotechnology in Drug Delivery | |
| HK40080633A (en) | Engineered platelets for targeted delivery of a therapeutic agent | |
| Zhuang et al. | Biomedical Technology |